CytoVac

About:

Cytovac is a clinical-stage biopharmaceutical company.

Description:

Cytovac is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies with a primary focus towards orphan diseases. The company is a leader in the rapidly developing field of individualized cell-based therapies for solid tumors, and is using the ALECSAT platform to generate best-in- class therapeutics to treat cancer with a high unmet medical need.

Total Funding Amount:

$2.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hørsholm, Hovedstaden, Denmark

Founded Date:

2008-02-11

Contact Email:

info(AT)cytovac.dk

Founders:

Alexei Kirkin, Bent Alsø, Karine Dzhandzhougazyan

Number of Employees:

11-50

Last Funding Date:

2019-07-04

IPO Status:

Private

Industries: